Image-guided bone marrow aspirate concentrate and platelet-rich plasma therapy for a chronic high-grade anterior cruciate ligament tear: a case report
DOI:
https://doi.org/10.18203/2320-6012.ijrms20263126Keywords:
Anterior crucial ligament, Bone marrow aspirate concentrate, Platelet rich plasma, Regenerative OrthobiologicsAbstract
The anterior cruciate ligament (ACL) is a critical stabilizing structure of the knee joint, responsible for maintaining both anteroposterior and rotational stability. ACL injuries are among the most common sports-related ligamentous injuries to cause debilitating condition. Surgical reconstruction forms the end point of recommendation, nevertheless emerging techniques like orthobiologics using bone marrow aspirate concentrate (BMAC) and platelet-rich plasma (PRP) form alternate therapy. A 26-year-old male cyclist and fitness enthusiast presented with chronic knee instability and functional limitation secondary to a high-grade ACL tear. The patient continued to experience recurrent episodes of instability and was advised to undergo ACL reconstruction. Reluctant to pursue surgical intervention, the patient opted to undergo image-guided orthobiologic treatment. BMAC and high-concentration PRP were administered under ultrasound and fluoroscopic guidance directly into the injured ACL fibers, infrapatellar region, and intra-articular compartment. The procedure was performed on an outpatient basis. Clinical follow-up demonstrated progressive functional improvement over six months. Resting pain resolved within the first month, while objective clinical examination revealed improvement in ligament stability as reflected by Lachman test (Grade II to Grade I) with a firm endpoint. At six months, the patient reported approximately 90% functional recovery, complete resolution of subjective instability episodes, and successful return to long-distance cycling, aerobic exercise, and agility-based activities without pain or stiffness which was noteworthy. The observed clinical and functional improvements suggest that targeted regenerative intervention(s) offer feasible line of treatment in the management of ACL tear where conventional conservative management has failed.
References
Kiapour AM, Murray MM. Basic science of anterior cruciate ligament injury and repair. Bone Joint Res. 2014;3(2):20-31.
Murray MM, Fleming BC. Biology of anterior cruciate ligament injury and repair: Kappa Delta Ann Doner Vaughn Award paper 2013. J Orthop Res. 2013;31(10):1501-6.
Moses B, Orchard J, Orchard J. Systematic review: annual incidence of ACL injury and surgery in various populations. Res Sports Med. 2012;20(3-4):157-79.
Griffin LY, Albohm MJ, Arendt EA, Bahr R, Beynnon BD, Demaio M, et al. Understanding and preventing noncontact anterior cruciate ligament injuries: a review of the Hunt Valley II meeting, January 2005. Am J Sports Med. 2006;34(9):1512-32.
Boden BP, Dean GS, Feagin JA Jr, Garrett WE Jr. Mechanisms of anterior cruciate ligament injury. Orthopedics. 2000;23(6):573-8.
Lohmander LS, Englund PM, Dahl LL, Roos EM. The long-term consequence of anterior cruciate ligament and meniscus injuries: osteoarthritis. Am J Sports Med. 2007;35(10):1756-69.
Murray MM, Martin SD, Martin TL, Spector M. Histological changes in the human anterior cruciate ligament after rupture. J Bone Joint Surg Am. 2000;82(10):1387-97.
van Melick N, Hoogeboom TJ, Pronk Y, Rutten B, van Tienen TG, Nijhuis-van der Sanden MWG, et al. Less than half of ACL-reconstructed athletes are cleared for return to play based on practice guideline criteria: results from a prospective cohort study. Int J Sports Phys Ther. 2020;15(6):1006-18.
Frobell RB, Roos HP, Roos EM, Roemer FW, Ranstam J, Lohmander LS. Treatment for acute anterior cruciate ligament tear: five year outcome of randomised trial. BMJ. 2013;346:f232.
Filbay SR, Grindem H. Evidence-based recommendations for the management of anterior cruciate ligament (ACL) rupture. Best Pract Res Clin Rheumatol. 2019;33(1):33-47.
Dhillon MS, Behera P, Patel S, Shetty V. Orthobiologics and platelet rich plasma. Indian J Orthop. 2014;48(1):1-9.
Chamberlain CS, Saether EE, Aktas E, Vanderby R. Mesenchymal stem cell therapy on tendon/ligament healing. J Cytokine Biol. 2017;2(1):112.
Kanaya A, Deie M, Adachi N, Nishimori M, Yanada S, Ochi M. Intra-articular injection of mesenchymal stromal cells in partially torn anterior cruciate ligaments in a rat model. Arthroscopy. 2007;23(6):610-7.
Movva V, Alluru A, Khaleel S, Manne Mudhu S, Venkatesan V. Proof of concept to portray management of early and mid-stage avascular necrosis with bone marrow aspirate concentrate and high concentrate plasma augmentation, post percutaneous core decompression-an orthobiologics approach. Int J Res Orthop. 2026;12(2):401-5.
Movva V, Venkatesan V, Khaleel S, Manne Mudhu S, Birineni S, Nagalla B. Therapeutic efficacy of bone marrow aspirate and platelet enriched plasma (autologous) studied in osteoarthritic patients: proof of concept study. World J Pharm Res. 2023;12(13):1163-79.
van der List JP, DiFelice GS. Primary repair of the anterior cruciate ligament: a paradigm shift. Surgeon. 2017;15(3):161-8.
Canapp SO Jr, Leasure CS, Cox C, Ibrahim V, Carr BJ. Partial cranial cruciate ligament tears treated with stem cell and platelet-rich plasma combination therapy in 36 dogs: a retrospective study. Front Vet Sci. 2016;3:112.
Kim SJ, Song DH, Park JW, Park S, Kim SJ. Effect of bone marrow aspirate concentrate-platelet-rich plasma on tendon-derived stem cells and rotator cuff tendon tear. Cell Transplant. 2017;26(5):867-78.
Centeno CJ, Berger DR, Pitts J, Markle J, Pelle AJ, Murphy M, et al. Non-surgical treatment of anterior cruciate ligament tears with percutaneous bone marrow concentrate and platelet products versus exercise therapy: a randomized-controlled, crossover trial with 2-year follow-up. BMC Musculoskelet Disord. 2025;26:882.
Murray IR, King JB, Mafi R, Mafi P, Smith AM, Hossain FM, et al. Autologous cell-based therapy for tendon and ligament regeneration—a systematic review of clinical evidence. Cytotherapy. 2016;18(9):1097-113.
Sampath SJP, Kotikalapudi N, Venkatesan V. A novel therapeutic combination of mesenchymal stem cells and stigmasterol to attenuate osteoarthritis in rodent model system—a proof of concept study. Stem Cell Investig. 2021;8:5.
Dhillon MS, Behera P, Patel S, Shetty V. Orthobiologics and platelet rich plasma. Indian J Orthop. 2014;48(1):1-9.
Jindal K, Patel S, Dhillon MS. The future of injectable orthobiologic substances for knee osteoarthritis: Options beyond platelet-rich plasma. J Musculoskelet Surg Res. 2020;4(3):173-81.